# Oxaliplatin

NDC: 68083-176
Generic name: Oxaliplatin
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20171106

FDA application: ANDA207325

## Active ingredients

- OXALIPLATIN: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-176"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-176
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6f89dc3-a594-4b5b-8728-272e20c1ecb5